Gastric fundic gland polyps in patients undergoing routine upper gastrointestinal endoscopy

Gastric fundic gland polyps in patients undergoing routine upper gastrointestinal endoscopy - FGP-ROUGAS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30802

Enrollment

900

Registered

2007-01-09

Start date

2007-05-04

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric fundic gland polyps

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age > or = 18 years signed informed consent cases: endoscopical presence of gastric fundic gland polyps controls: no endoscopical presence of gastric fundic gland polyps

Exclusion criteria

Exclusion criteria: coagulation disorder use of warfarin or other anti-coagulant medication if uncorrected at the time of endoscopy liver cirrhosis

Design outcomes

Primary

Measure	Time frame
Description of - the prevalence of gastric fundic gland polyps in this population - the prevalence of dysplasia in these gastric fundic gland polyps - the prevalence of gastritis, atrophy, intestinal metaplasia, dysplasia and Helicobacter pylori - the serum levels of gastrin, pepsinogen I and II, and anti-Helicobacter pylori antibodies. - the results of the questionnaire assessment	—

Countries

Netherlands

Outcome results